K. Beckmann

发表

Variation in the management of early breast cancer in rural and metropolitan centres: implications for the organisation of rural cancer services.

D. Roder, P. Craft, Yanping Zhang, 2010, Breast.

Australian primary schools' sun protection policy and practice: evaluating the impact of the National SunSmart Schools Program.

K. Beckmann, Simeon B W Jones, J. Rayner, 2008, Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals.

Children's sun exposure and sun protection: prevalence in Australia and related parental factors.

J. Aitken, A. Reeder, M. Wakefield, 2012, Journal of the American Academy of Dermatology.

The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening

László Tabár, Peter B. Dean, Stephen W. Duffy, 2018, Cancer.

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

P. Stattin, J. Adolfsson, K. Beckmann, 2018, PloS one.

Student Conference Abstracts

K. Beckmann, E. Buckley, M. Borg, 2018, Journal of Medical Radiation Sciences.

Impact of hormone replacement therapy use on mammographic screening outcomes

G. Farshid, D. Roder, K. Beckmann, 2013, Cancer Causes & Control.

Prostate cancer outcomes for men who present with symptoms at diagnosis

D. Roder, R. Ruseckaite, K. Beckmann, 2017, BJU international.

Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage.

K. Beckmann, G. Young, D. Roder, 2014, Journal of evaluation in clinical practice.

,Q¡XHQFHRI0DPPRJUDSKLF6FUHHQLQJRQ%UHDVW&DQFHU Incidence Trends in South Australia

D. Murray, K. Beckmann, J. Hiller, 2014 .

Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset

D. Roder, J. Zalcberg, R. Ruseckaite, 2016, BMC Research Notes.

A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate Cancer.

R. Popert, O. Elhage, K. Beckmann, 2019, European urology oncology.

Clinical and socio‐demographic profile of an Australian multi‐institutional prostate cancer cohort

D. Roder, C. Pinnock, K. Beckmann, 2009 .

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic

S. Irshad, D. Josephs, K. Beckmann, 2020, Frontiers in Physiology.

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database

P. Dasgupta, R. Popert, O. Elhage, 2021, BMC cancer.

Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care

C. Luke, K. Pittman, T. Price, 2008, Australian and New Zealand journal of public health.

Changes in five‐year survival for people with acute leukaemia in South Australia, 1980–2016

D. Roder, K. Beckmann, Ming Li, 2022, The Medical journal of Australia.

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

Christopher P. Filson, D. Nieboer, E. Steyerberg, 2021, European urology open science.

Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre

P. Dasgupta, R. Popert, O. Elhage, 2021, Prostate Cancer and Prostatic Diseases.

Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment

K. Beckmann, M. Oehler, I. Olver, 2021, Cancer management and research.

Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial

V. Goh, G. Whyte, J. Lagergren, 2022, British Journal of Sports Medicine.

Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity

Jared M. Campbell, J. McNeil, D. Roder, 2017, Clinical genitourinary cancer.

Tools for Predicting Clinical and Patient‐reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity

Jared M. Campbell, J. McNeil, D. Roder, 2017, Clinical genitourinary cancer.

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016

P. Stattin, K. Beckmann, P. Nilsson, 2020, Acta oncologica.

Short‐term outcomes after surgical resection for colorectal cancer in South Australia

D. Roder, K. Beckmann, G. Young, 2017, Journal of evaluation in clinical practice.

Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis

D. Dodwell, J. Dahlstrom, K. Beckmann, 2022, BMJ.

Developing a consensus statement for psychosocial support in active surveillance for prostate cancer

K. Beckmann, D. Cahill, M. van Hemelrijck, 2022, BJUI compass.

Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia

P. Iosifidis, G. Farshid, C. Luke, 2008, Breast Cancer Research and Treatment.

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results

H. Olsson, M. Eklund, J. Adolfsson, 2019, JAMA network open.

Antibodies as biomarkers for cancer risk: a systematic review

K. Beckmann, S. Karagiannis, M. van Hemelrijck, 2022, Clinical and experimental immunology.

Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins

D. Cunningham, W. Allum, J. Lagergren, 2021, Acta oncologica.

Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin

D. Cunningham, W. Allum, J. Lagergren, 2020, The British journal of surgery.

Patient-reported functional outcome measures and treatment choice for prostate cancer

K. Ettridge, K. Beckmann, B. Higgs, 2022, BMC Urology.

Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.

Jared M. Campbell, J. McNeil, D. Roder, 2017, International journal of radiation oncology, biology, physics.

Patient reported outcomes following radiation therapy in men with prostate cancer : a systematic review of prognostic tool accuracy and validity Running title : Radiation therapy PROMS

Jared M. Campbell, J. McNeil, D. Roder, 2017 .

Solaria compliance with the Australia/New Zealand Standard in Adelaide.

K. Beckmann, Simeon B W Jones, J. Rayner, 2008, Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals.

CMAR_A_309551 4633..4645

K. Beckmann, M. Oehler, I. Olver, 2021 .

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

D. Nieboer, B. Trock, P. Dasgupta, 2022, European urology open science.

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis

K. Beckmann, N. Hammar, G. Walldius, 2021, Cancers.

Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer

K. Beckmann, D. Cahill, M. van Hemelrijck, 2021, Translational andrology and urology.

Australian validation of the Cancer of the Prostate Risk Assessment Post‐Surgical score to predict biochemical recurrence after radical prostatectomy

J. McNeil, D. Roder, K. Beckmann, 2018, ANZ journal of surgery.

Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades—trends by age and in the elderly

G. Farshid, D. Roder, J. Kollias, 2017, Journal of evaluation in clinical practice.

Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre

P. Dasgupta, R. Popert, O. Elhage, 2021, Prostate Cancer and Prostatic Diseases.

Quantifying breast cancer over-diagnosis in an organised mammography screening program.

K. Beckmann, 2014 .

An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review

Jared M. Campbell, J. McNeil, D. Roder, 2017, Radiation oncology.

Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune‐related adverse events after immune checkpoint inhibitor therapy

M. Brown, K. Beckmann, C. Karapetis, 2020, Asia-Pacific journal of clinical oncology.

Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort.

D. Roder, P. Craft, J. Buckingham, 2011, Breast.

PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design

L. Holmberg, L. Egevad, H. Adami, 2019, BMJ Open.

Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings

D. Roder, K. Beckmann, S. Evans, 2019, Asian journal of urology.

Negative first follow‐up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment

P. Dasgupta, R. Popert, O. Elhage, 2020, BJU international.

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

L. Holmberg, P. Stattin, J. Adolfsson, 2020, Prostate Cancer and Prostatic Diseases.

Prevalence and determinants of Australian adolescents' and adults' weekend sun protection and sunburn, summer 2003-2004.

J. Aitken, A. Reeder, M. Wakefield, 2008, Journal of the American Academy of Dermatology.

Dietary, physical activity and sedentary behaviour among Australian secondary students in 2005.

V. White, K. Beckmann, H. Dixon, 2007, Health promotion international.

Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer

E. Platz, S. Rohrmann, W. Nelson, 2022, Cancer Causes & Control.

Effect of Mammography Screening on Mortality by Histological Grade

L. Tabár, S. Duffy, T. Chen, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review

L. Tabár, S. Duffy, T. Chen, 2016, Journal of medical screening.

Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects

S. Duffy, G. Farshid, D. Roder, 2015, Journal of medical screening.

A novel case–control design to estimate the extent of over‐diagnosis of breast cancer due to organised population‐based mammography screening

S. Duffy, G. Farshid, D. Roder, 2015, International journal of cancer.

Influence of mammographic screening on breast cancer incidence trends in South Australia.

G. Farshid, D. Roder, K. Beckmann, 2014, Asian Pacific journal of cancer prevention : APJCP.

Incidence Trends in South Australia

G. Farshid, D. Roder, K. Beckmann, 2014 .

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

L. Holmberg, P. Stattin, J. Adolfsson, 2019, BMC Cancer.

Supporting cancer control for Indigenous Australians: initiatives and challenges for cancer councils.

K. Beckmann, S. Thompson, Shaouli Shahid, 2008, Australian health review : a publication of the Australian Hospital Association.

Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity

J. McNeil, J. Campbell, D. Roder, 2017, Prostate Cancer and Prostatic Diseases.

Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study

S. Cole, D. Roder, K. Beckmann, 2015, BMC Health Services Research.

Assessing impact of organised breast screening across small residential areas—development and internal validation of a prediction model

G. Farshid, D. Roder, T. Niyonsenga, 2017, European journal of cancer care.

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

L. Holmberg, P. Stattin, J. Adolfsson, 2020, Prostate Cancer and Prostatic Diseases.

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

P. Stattin, J. Adolfsson, B. Lindahl, 2020, Frontiers in Oncology.

Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank

K. Beckmann, R. Travis, B. Russell, 2020, International journal of cancer.

ISUP Group 4 – a Homogenous Group of Prostate Cancers?

K. Beckmann, P. Cohen, T. C. Lu, 2018, Pathology & Oncology Research.

Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.

L. Holmberg, P. Stattin, J. Adolfsson, 2019, European urology.

Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients

Catherine Han Lin, M. Kattan, D. Nieboer, 2021, Translational Andrology and Urology.

Do breast cancer risk factors differ among those who do and do not undertake mammography screening?

G. Farshid, D. Roder, K. Beckmann, 2013, Journal of medical screening.

Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015.

K. Beckmann, E. Buckley, M. Borg, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

D. Roder, R. Ruseckaite, K. Beckmann, 2016, BMC Cancer.

Is a Chronic Disease Self-Management Program Beneficial to People Affected by Cancer?

K. Beckmann, J. Hermann, Kathriye Strassnick, 2007 .

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

P. Stattin, K. Beckmann, H. Garmo, 2021, Cancers.

Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists

D. Roder, K. Beckmann, H. Banwell, 2023, Journal of Foot and Ankle Research.

Impact of hormone replacement therapy use on mammographic screening outcomes

G. Farshid, D. Roder, K. Beckmann, 2013, Cancer Causes & Control.

Factors impacting on sexual function among men on active surveillance for prostate cancer

K. Ettridge, K. Beckmann, A. Jay, 2023, The Prostate.

Risk of progression following a negative biopsy in prostate cancer active surveillance

P. Dasgupta, A. Villers, O. Elhage, 2022, Prostate Cancer and Prostatic Diseases.

Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project.

P. Craft, Yanping Zhang, A. Rezo, 2013, Breast.

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

D. Roder, R. Ruseckaite, K. Beckmann, 2016, BMC Cancer.

Breast cancer screening—opportunistic use of registry and linked screening data for local evaluation

G. Farshid, D. Roder, J. Kollias, 2017, Journal of evaluation in clinical practice.

Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings

D. Roder, K. Beckmann, S. Evans, 2017, BMC Cancer.

Imaging Biomarkers as Predictors for Breast Cancer Death

L. Tabár, S. Duffy, T. Tot, 2019, Journal of oncology.

Pre‐treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer

B. Koczwara, K. Beckmann, C. Karapetis, 2018, Asia-Pacific journal of clinical oncology.

Nodal-negatives, ER-positives Mammakarzinom

K. Beckmann, 2005, Der Gynäkologe.

Clinical outcomes for men with positive surgical margins after radical prostatectomy—results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registry

K. Beckmann, K. Moretti, A. Vincent, 2022, Asian journal of urology.

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Catherine Han Lin, D. Nieboer, E. Steyerberg, 2022, The Prostate.

GxE PRS: Genotype-environment interaction in polygenic risk score models for quantitative and binary traits

B. Benyamin, E. Hypponen, K. Beckmann, 2023, bioRxiv.

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

H. Olsson, M. Eklund, J. Adolfsson, 2019, BMC Urology.